Ali Ramezani

2.9k total citations · 1 hit paper
50 papers, 2.2k citations indexed

About

Ali Ramezani is a scholar working on Molecular Biology, Genetics and Virology. According to data from OpenAlex, Ali Ramezani has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 22 papers in Genetics and 10 papers in Virology. Recurrent topics in Ali Ramezani's work include Virus-based gene therapy research (22 papers), CRISPR and Genetic Engineering (16 papers) and RNA Interference and Gene Delivery (10 papers). Ali Ramezani is often cited by papers focused on Virus-based gene therapy research (22 papers), CRISPR and Genetic Engineering (16 papers) and RNA Interference and Gene Delivery (10 papers). Ali Ramezani collaborates with scholars based in United States, Canada and Iran. Ali Ramezani's co-authors include Robert G. Hawley, Teresa S. Hawley, Manuel Velasquez, Dominic Raj, Dominic S. Raj, Pieter Evenepoel, Ziad A. Massy, Björn Meijers, Raymond Vanholder and Rachel L. Lewis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Oncogene.

In The Last Decade

Ali Ramezani

49 papers receiving 2.1k citations

Hit Papers

Trimethylamine N-Oxide: The Good, the Bad and the Unknown 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Ramezani United States 24 1.6k 650 376 200 193 50 2.2k
Gang Ning United States 13 746 0.5× 364 0.6× 120 0.3× 173 0.9× 120 0.6× 21 1.9k
Ralph Zalusky United States 24 930 0.6× 281 0.4× 470 1.3× 430 2.1× 91 0.5× 50 3.2k
John McClary United States 10 1.5k 0.9× 282 0.4× 222 0.6× 84 0.4× 68 0.4× 12 2.5k
Prasun K. Datta United States 25 860 0.5× 156 0.2× 112 0.3× 94 0.5× 65 0.3× 67 1.7k
Thomas L. Eggerman United States 24 995 0.6× 228 0.4× 208 0.6× 341 1.7× 89 0.5× 60 2.4k
Lee Anne Tibbles Canada 21 1.5k 1.0× 200 0.3× 142 0.4× 523 2.6× 67 0.3× 36 2.7k
Carl J. Bentzel United States 23 1.0k 0.7× 166 0.3× 242 0.6× 187 0.9× 237 1.2× 46 2.4k
Ewa Bryl Poland 27 612 0.4× 212 0.3× 351 0.9× 351 1.8× 170 0.9× 103 3.2k
Lucinda Furci Italy 17 468 0.3× 130 0.2× 193 0.5× 109 0.5× 46 0.2× 28 1.5k

Countries citing papers authored by Ali Ramezani

Since Specialization
Citations

This map shows the geographic impact of Ali Ramezani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Ramezani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Ramezani more than expected).

Fields of papers citing papers by Ali Ramezani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Ramezani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Ramezani. The network helps show where Ali Ramezani may publish in the future.

Co-authorship network of co-authors of Ali Ramezani

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Ramezani. A scholar is included among the top collaborators of Ali Ramezani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Ramezani. Ali Ramezani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makvandi, Manoochehr, Shahram Jalilian, Ebrahim Faghihloo, et al.. (2022). Prevalence of Human Papillomavirus and Co-Infection with Epstein-Barr Virus in Oral and Oropharyngeal Squamous Cell Carcinomas. Asian Pacific Journal of Cancer Prevention. 23(11). 3931–3937. 10 indexed citations
2.
Zandi, Milad, Saber Soltani, Mona Fani, et al.. (2021). Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children. Osong Public Health and Research Perspectives. 12(5). 286–292. 11 indexed citations
3.
Ramezani, Ali, et al.. (2018). The role of Nrf2 transcription factor in viral infection. Journal of Cellular Biochemistry. 119(8). 6366–6382. 71 indexed citations
4.
Ramezani, Ali, et al.. (2017). Gut Microbiome in Chronic Kidney Disease. Current Hypertension Reports. 19(4). 29–29. 51 indexed citations
5.
Ramezani, Ali, Ziad A. Massy, Björn Meijers, et al.. (2015). Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. American Journal of Kidney Diseases. 67(3). 483–498. 296 indexed citations
6.
Ahangarpour, Akram, et al.. (2013). THE EFFECT OF BOSWELLIA SERRATA ON BLOOD GLUCOSE, INSULIN LEVEL AND INSULIN RESISTANCE IN TYPE 2 DIABETIC PATIENTS. 20(103). 11–18. 6 indexed citations
7.
Shokrgozar, Mohammad Ali, et al.. (2011). High Vero Cell Density and Rabies Virus Proliferation on Fibracel Disks Versus Cytodex-1 in Spinner Flask. Pakistan Journal of Biological Sciences. 14(7). 441–448. 9 indexed citations
8.
Ramezani, Ali, et al.. (2011). Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice. Thrombosis and Haemostasis. 105(4). 676–687. 17 indexed citations
9.
Ohshiro, Kazufumi, Suresh K. Rayala, Caroline Wigerup, et al.. (2010). Acetylation‐dependent oncogenic activity of metastasis‐associated protein 1 co‐regulator. EMBO Reports. 11(9). 691–697. 33 indexed citations
10.
Ramezani, Ali, Teresa S. Hawley, & Robert G. Hawley. (2008). Reducing the Genotoxic Potential of Retroviral Vectors. Humana Press eBooks. 434. 183–203. 10 indexed citations
11.
Hong, Sunghoi, Dong‐Youn Hwang, Soonsang Yoon, et al.. (2007). Functional Analysis of Various Promoters in Lentiviral Vectors at Different Stages of In Vitro Differentiation of Mouse Embryonic Stem Cells. Molecular Therapy. 15(9). 1630–1639. 110 indexed citations
12.
Hawley, Robert G., Ali Ramezani, & Teresa S. Hawley. (2006). Hematopoietic Stem Cells. Methods in enzymology on CD-ROM/Methods in enzymology. 419. 149–179. 33 indexed citations
13.
Ramezani, Ali. (2006). Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes. Frontiers in bioscience. 11(1). 2940–2940. 3 indexed citations
14.
Haviernik, Peter, Heath L. Bradley, Teresa S. Hawley, et al.. (2004). Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation. Oncogene. 23(57). 9212–9219. 12 indexed citations
15.
Saenko, Evgueni L., Natalya M. Ananyeva, Morvarid Moayeri, Ali Ramezani, & Robert G. Hawley. (2003). Development of Improved Factor VIII Molecules and New Gene Transfer Approaches for Hemophilia A. Current Gene Therapy. 3(1). 27–41. 27 indexed citations
16.
Yamada, Kaoru, Ali Ramezani, Robert G. Hawley, et al.. (2003). Phenotype correction of fanconi anemia group a hematopoietic stem cells using lentiviral vector. Molecular Therapy. 8(4). 600–610. 23 indexed citations
17.
Ramezani, Ali, et al.. (1999). Targeted RNases: a feasibility study for use in HIV gene therapy. Gene Therapy. 6(5). 913–921. 11 indexed citations
18.
Ramezani, Ali & Sadhna Joshi. (1996). Comparative Analysis of Five Highly Conserved Target Sites Within the HIV-1 RNA for Their Susceptibility to Hammerhead Ribozyme-Mediated Cleavage In Vitro and In Vivo. Antisense and Nucleic Acid Drug Development. 6(3). 229–235. 26 indexed citations
20.
Ramezani, Ali, et al.. (1993). The Development and Testing of Retroviral Vectors Expressing Trans -Dominant Mutants of HIV-1 Proteins to Confer Anti-HIV-1 Resistance. Human Gene Therapy. 4(5). 625–634. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026